Skip Navigation
Skip to contents

ICDM 2026

Program details

Education course
Education course 1 Essential course Chair(s): So Hun Kim, Su jin Jeong
Saturday 17 October, 09:00~10:20
Room 5
Optimal diabetes management increasingly demands an integrated understanding of cardiometabolic comorbidities and holistic patient care. This essential course addresses three critical areas of contemporary diabetes practice. Speakers will outline the evolving therapeutic landscape for diabetic kidney disease, spanning renin–angiotensin–aldosterone system blockade, mineralocorticoid receptor antagonists, and GLP-1 receptor agonists. The course further provides a concise yet comprehensive update on pharmacological strategies for metabolic dysfunction-associated steatotic liver disease, as well as evidence-based approaches to achieving and sustaining clinically meaningful weight loss in patients with diabetes. Together, these lectures equip diabetes educators with essential, practice-ready knowledge to address the multifaceted challenges of modern diabetes care.
Mi Kyung Kim EC1-L1
Mi Kyung KimKeimyung University, Korea
Evolving treatment strategies in diabetic kidney disease: from RAAS blockade to MRA and GLP-1 RAs
Eugene Han EC1-L2
Eugene HanKeimyung University, Korea
Current and emerging treatments for MASLD: an update
Boyeon Kim EC1-L3
Boyeon KimSoonchunhyang University, Korea
Achieving and maintaining weight loss in patients with diabetes
Education course 2 Advanced course Chair(s): Ji A Seo, Da Hea Seo
Saturday 17 October, 13:30~14:50
Room 5
Building on foundational knowledge, this advanced course addresses specialized topics that challenge diabetes educators in real-world practice. The first lecture explores atypical forms of diabetes offering a practical framework for accurate classification and individualized treatment. The second lecture highlights key educational points for insulin pump therapy to maximize efficacy and patient safety. The course concludes with evidence-based guidance on optimizing resistance exercise for patients on injectable therapies, integrating pharmacological and lifestyle considerations. Together, these lectures sharpen clinical decision-making and elevate patient-centered diabetes education across Asia.
Sang-Man Jin EC2-L1
Sang-Man JinSungkyunkwan University, Korea
Differentiating type 1 and type 2 diabetes: diagnostic challenges and treatment strategies
Su-ji Lee EC2-L2
Su-ji LeeKangbuk Samsung Hospital, Korea
Key educational points for insulin pump therapy
Seungjae Jeong EC2-L3
Seungjae JeongSamsung Medical Center, Korea
Optimizing resistance exercise in patients with diabetes on injectable therapies
KDA 대한당뇨병학회Korean Diabetes Association
  • (04146) 101-2104, Lotte Castle President, 109 Mapo-gu, Seoul, Korea
  • Tel: +82-2-714-9064 | E-mail: diabetes@kams.or.kr
  • Business Registration Number: 106-82-31108 | Name of Representative: Sung Rae Kim
Congress Secretariat (Planbear)
  • #1108, 220, Gonghang-daero, Gangseo-gu, Seoul(07806), Republic of Korea
  • Tel: +82-2-6734-1015 | E-mail: diabetes@planbear.co.kr